TrialBMC ophthalmology2021

Decrease in choroidal blood flow after half and one-third dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy.

Shun Kumashiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.